Cargando…
Hepatic manifestations and impact of COVID-19 on the cirrhotic patient()
The novel SARS-CoV-2 coronavirus is responsible for the infectious disease caused by coronavirus 19 (COVID-19). The current pandemic is growing worldwide and could affect 50-60% of the world population in the months to come. The most severe disease manifestations are atypical pneumonia and sepsis, b...
Autores principales: | Velarde-Ruiz Velasco, J.A., García-Jiménez, E.S., Remes-Troche, J.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346816/ http://dx.doi.org/10.1016/j.rgmxen.2020.05.002 |
Ejemplares similares
-
Manifestaciones hepáticas y repercusión en el paciente cirrótico de COVID-19
por: Velarde-Ruiz Velasco, J.A., et al.
Publicado: (2020) -
The Liver and COVID‐19 in Mexico
por: Remes‐Troche, José María, et al.
Publicado: (2021) -
Changes in physical activity and its impact on MAFLD during the COVID-19 pandemic
por: García-Carvajal, MJJ, et al.
Publicado: (2022) -
Fr015 FACTORS RELATED TO NEW ONSET DYSPEPSIA AFTER COVID 19 INFECTION IN MEXICAN POPULATION
por: Rendon, Ricardo Flores, et al.
Publicado: (2021) -
Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit
por: Álvaro-Meca, Alejandro, et al.
Publicado: (2016)